Rahsaan Thompson has joined the company as General Counsel (news posted on April 6 2020).
Rahsaan Thompson has joined the company as General Counsel (news posted on September 26 2019).
Aziz Mottiwala has joined the company as Chief Commercial Officer (news posted on September 26 2019).
Create an alert
to follow the executive moves at Opiant Pharmaceuticals.
Zyla Life Sciences and Assertio Therapeutics have announced they will merge (posted on Mar 17, 2020).
Dermapharm has announced the acquisition of Allergopharma (posted on Feb 19, 2020).
Qualigen has announced the acquisition of Ritter Pharmaceuticals (posted on Jan 21, 2020).
Opiant Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate Update | Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals to Report Fourth Quarter 2019 Financial Results and Host Conference Call and Webcast on Wednesday, March 4 | Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals Announces Development Collaboration with National Center for Advancing Translational Sciences for the Development of OPNT004 for the Treatment of Acute Cannabinoid Overdose | Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals Announces Contract Extension of Second Tranche of Approximately $2.4 Million from Biomedical Advanced Research and Development Authority for Development of OPNT003, Nasal Nalmefene, for the Treatment of Opioid Overdose | Opiant Phar
Opiant Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update | Opiant Pharmaceuticals, Inc.
Learn about your clients' org charts. Understand their industries and their competitors.
View the executives' biographies. Contact the executives through our email platform.
Select key words to follow your clients. Receive alerts when executive movements happen.
File your clients in folders. Add private notes. Download our data in Excel on your PC.